OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Webinar on Verified Antigen
Verified Antigen Webinar

Browse all lysates


spacer
OriGene in recent publications
Sensitive and low-background electrochemical assay of corin activity via supramolecular recognition and rolling circle amplification Anal. Chim. Acta May 2016 [CORIN]

Extracellular HSP110 skews macrophage polarization in colorectal cancer OncoImmunology Apr 2016 [HSPH1]

TRPV3 expression and vasodilator function in isolated uterine radial arteries from non-pregnant and pregnant rats Vascul. Pharmacol. Apr 2016 [TRPV3]

Alpha-Actinin-4 is a Possible Target Protein for Aristolochic Acid I in Human Kidney Cells In Vitro Am. J. Chin. Med. Apr 2016 [ACTN4]

View All Citations >>

spacer

111 Protein belong to pathway "bladder cancer"

divider

  Page: 1 of 6 
Direct Download
spacer
SKUAccnSymbolDescriptionShipping
TP301156NM_000075CDK4Recombinant protein of human cyclin-dependent kinase 4 (CDK4)In Stock
TP720874NM_000075CDK4Purified recombinant protein of Human cyclin-dependent kinase 4 (CDK4)5 days
TP720567NM_000389CDKN1ARecombinant protein of human cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A), transcript variant 15 Days
TP301765NM_078467CDKN1ARecombinant protein of human cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A), transcript variant 2In Stock
TP320937NM_000077CDKN2ARecombinant protein of human cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 1In Stock
TP723347NM_000077CDKN2APurified recombinant protein of Human cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 1.5 Days
TP723348NM_000077CDKN2APurified recombinant protein of Human cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 1.5 Days
TP315423NM_004938DAPK1Recombinant protein of human death-associated protein kinase 1 (DAPK1)2 Weeks
TP313427NM_001348DAPK3Recombinant protein of human death-associated protein kinase 3 (DAPK3)In Stock
TP308247NM_005225E2F1Recombinant protein of human E2F transcription factor 1 (E2F1)In Stock
TP760363NM_001949E2F3Purified recombinant protein of Human E2F transcription factor 3 (E2F3), full length, with N-terminal HIS tag, expressed in E.Coli, 50ugIn Stock
TP302170NM_001953TYMPRecombinant protein of human thymidine phosphorylase (TYMP), transcript variant 2In Stock
TP310817NM_001963EGFRecombinant protein of human epidermal growth factor (beta-urogastrone) (EGF)In Stock
TP720580NM_001963EGFPurified recombinant protein of Human epidermal growth factor (EGF), transcript variant 15 days
TP723068NM_001963EGFPurified recombinant protein of Human epidermal growth factor (EGF), transcript variant 1.5 Days
TP723821NM_001963EGFPurified recombinant protein of Human epidermal growth factor (EGF), transcript variant 15 days
TP700043NM_005228EGFRRecombinant protein of human epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR),residues 25-645 aa, expressed in human cellsIn Stock
TP700065NM_005228EGFRPurified protein of Homo sapiens epidermal growth factor receptor (EGFR), transcript variant 1, mutant L858R, with C-terminal MYC/DDK tag, expressed in human cells, 20ugIn Stock
TP700080NM_005228EGFRPurified protein of Homo sapiens epidermal growth factor receptor (EGFR), transcript variant 1, mutant K745_K750del, with C-terminal MYC/DDK tag, expressed in human cells, 20ugIn Stock
TP710003NM_005228EGFRRecombinant protein of human epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR),residues 1-645aa,expressed in sf9 cellsIn Stock

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title